SEC Form 4 · accession 0001493152-26-030210
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kameel D. Farag
Officer — Interim CFO
Period of report
Jun 24, 2026
Accepted (ET)
Jun 25, 2026 · 8:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 1,248 | $10.02 | A | 2,870 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 1,395 | $9.32 | A | 4,265 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 1,570 | $8.28 | A | 5,835 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 2,539 | $5.12 | A | 8,374 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 3,725 | $3.49 | A | 12,099 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 7,353 | $3.74 | A | 19,452 | D | |
| American Depositary Shares representing Ordinary SharesF1 | Jun 24, 2026 | A | 1,000 | $13.00 | A | 20,452 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.